Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Oct 2015

Yurgelun Matthew B, Hiller Elaine, Garber Judy E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Counseling
Share to Cultural Characteristics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ethnicity

Share to Health Services Accessibility

Share to Healthcare Disparities

Share to Racial Groups

Source

Identifiers

PMID: 26282646
DOI: 10.1200/JCO.2015.60.8596

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?PMID 26282646Read ↗

Pros and cons of screening for BRCA mutations.Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

BRCA screening.Semantic proximity Read ↗

Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidence.Semantic proximity Read ↗

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.Semantic proximity Read ↗

Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations.Semantic proximity Read ↗

Population screening requires robust evidence—genomics is no exceptionSemantic proximity Read ↗

BRCA1-BRCA2 mutation analysis results in 910 individuals: Mutation distribution and 8 novel mutations.Semantic proximity Read ↗

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.Semantic proximity Read ↗

Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.